during the late summer and fall, when COVID cases were at a low ebb—so low that not only did no one in Pfizer's vaccinated group die of COVID, nobody in its placebo group did either?
The Johnson & Johnson shot, meanwhile, was in the field during the winter spike in cases.Its study also included Brazil and South Africa—each home to a new COVID variant—as well as the U.S., and there were a quite respectable five COVID deaths in the placebo group (and none in the vaccinated group, as above).
In fact, if I was a flack for Johnson & Johnson who drank too much on Twitter, I could plausibly boast that my company's shot was the only one battle-tested against the so-called South Africa variant.